Titan Biotech consolidated net profit rises 2.76% in the September 2024 quarter

Net profit of Titan Biotech rose 2.76% to Rs 6.70 crore in the quarter ended September 2024 as against Rs 6.52 crore during the previous quarter ended September 2023. Sales declined 8.15% to Rs 39.89 crore in the quarter ended September 2024 as against Rs 43.43 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	39.89	43.43	-8
OPM %	19.45	20.08	-
PBDT	7.81	8.99	-13
PBT	6.72	8.13	-17
NP	6.70	6.52	3